IGF2BP2 knockdown reduces colony-forming potential of AML progenitor cells, and Igf2bp2 loss delays disease progression in secondary transplant models, consistent with a functional role in LSC maintenance [41]. Here, IGF2BP2 is linked to acute myeloid leukemia.